Learn more

BIOTIE THERAPIES CORP

Overview
  • Total Patents
    191
  • GoodIP Patent Rank
    191,676
  • Filing trend
    0.0%
About

BIOTIE THERAPIES CORP has a total of 191 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1991. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PROBIODRUG AG, BAYER HEALTHCARE AG and WYETH CO.

Patent filings per year

Chart showing BIOTIE THERAPIES CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pihlavisto Marjo 54
#2 Smith David 54
#3 Szakonyi Zsolt 31
#4 Natunen Jari 29
#5 Johnson Mark 28
#6 Lazar Laszlo 28
#7 Jalkanen Markku 28
#8 Smith David John 26
#9 Karlsson Karl-Anders 25
#10 Vainio Petri 25

Latest patents

Publication Filing date Title
FI20115234A0 New pyridazinone and pyridone compounds
TW201134484A Therapeutic use
NZ706740A Use of vap-1 inhibitors for treating fibrotic conditions
WO2010146236A1 Urea substituted sulphonamide derivatives
FI20075278A0 Novel completely human anti-VAP-1 monoclonal antibodies
FI20075258A0 Procedure for selling responders for integrin inhibitors
FI20055498A0 Sulfonamides
FI20055496A0 Modulators that bind to the alpha-1 domain of collagen receptors
AU2004241060A1 Crystalline VAP-1 and uses thereof
WO2005090297A1 Sulphonamide derivatives
WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof
AU2003276307A1 High affinity receptors for helicobacter pylori and use thereof
AU2003255544A1 Tumor specific oligosaccharide epitopes and use thereof
TW200500465A Novel humanized anti-vap-1 monoclonal antibody
AU2003201619A1 Novel binding epitopes for helicobacter pylori and use thereof
PL368612A1 Method of treating alcoholism or alcohol abuse
CZ20031809A3 Glucuronyl-C5-epimerase, DNA encoding thereof and method for its use
US2003125360A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
HU0301625A2 1,3,4-oxadiazine-compounds as inhibitors of copper-containing amine oxidases, process for their preparation and their use for preparation of pharmaceutical compositions
US6492344B1 Syndecan enhancer element and syndecan stimulation of cellular differentiation